D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.6B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2951
Hudson Technologies
HDSN
$226M
| $2.35M | ﹤0.01% |
409,591
+50,909
| +14% | +$290K |
2023 Q3
11 quarters
|
|
2952
Spyre Therapeutics
SYRE
$8.44B
| $2.35M | ﹤0.01% |
+26,452
| New | +$1.93M |
2026 Q2
0 quarters
|
|
2953
Upwork
UPWK
$1.18B
| $2.35M | ﹤0.01% |
280,751
+179,735
| +178% | +$1.7M |
2019 Q2
28 quarters
|
|
2954
CALL
Arista Networks
ANET
$217B
| $2.34M | ﹤0.01% |
13,800
+8,300
| +151% | +$1.3M |
2017 Q1
37 quarters
|
|
2955
VanEck Morningstar Wide Moat ETF
MOAT
$11.8B
| $2.34M | ﹤0.01% |
22,523
+5,116
| +29% | +$517K |
2026 Q1
1 quarter
|
|
2956
Evolus
EOLS
$463M
| $2.34M | ﹤0.01% |
336,901
-222,149
| -40% | -$1.31M |
2021 Q1
21 quarters
|
|
2957
CALL
Enpro
NPO
$5.67B
| $2.34M | ﹤0.01% |
+6,200
| New | +$1.93M |
2026 Q2
0 quarters
|
|
2958
Revolution Medicines
RVMD
$40.1B
| $2.32M | ﹤0.01% |
12,400
-1,009,898
| -99% | -$148M |
2025 Q2
4 quarters
|
|
2959
Treace Medical Concepts
TMCI
$278M
| $2.32M | ﹤0.01% |
583,277
-257,992
| -31% | -$709K |
2023 Q1
13 quarters
|
|
2960
PUT
PENN Entertainment
PENN
$1.94B
| $2.32M | ﹤0.01% |
108,600
-192,600
| -64% | -$3.45M |
2025 Q4
2 quarters
|
|
2961
Standard BioTools
LAB
$239M
| $2.32M | ﹤0.01% |
2,818,026
+2,618,942
| +1,315% | +$2.47M |
2026 Q1
1 quarter
|
|
2962
Sprott Energy Transition Materials ETF
SETM
$428M
| $2.32M | ﹤0.01% |
74,338
+52,025
| +233% | +$1.84M |
2026 Q1
1 quarter
|
|
2963
PUT
Wendy's
WEN
$1.19B
| $2.32M | ﹤0.01% |
+279,300
| New | +$2M |
2026 Q2
0 quarters
|
|
2964
Futu Holdings
FUTU
$13.9B
| $2.31M | ﹤0.01% |
24,695
+23,007
| +1,363% | +$2.95M |
2025 Q4
2 quarters
|
|
2965
Broadstone Net Lease
BNL
$3.33B
| $2.31M | ﹤0.01% |
111,805
-90,424
| -45% | -$1.82M |
2025 Q2
4 quarters
|
|
2966
PUT
Sunrun
RUN
$1.83B
| $2.31M | ﹤0.01% |
172,600
-10,700
| -6% | -$144K |
2020 Q1
25 quarters
|
|
2967
PUT
BridgeBio Pharma
BBIO
$13.4B
| $2.3M | ﹤0.01% |
+30,900
| New | +$2.16M |
2026 Q2
0 quarters
|
|
2968
Amerant Bancorp
AMTB
$1.18B
| $2.3M | ﹤0.01% |
90,139
+11,651
| +15% | +$271K |
2025 Q1
5 quarters
|
|
2969
Pultegroup
PHM
$23.1B
| $2.29M | ﹤0.01% |
16,716
-103,989
| -86% | -$12.6M |
2025 Q4
2 quarters
|
|
2970
Vitamin Cottage Natural Grocers
NGVC
$725M
| $2.29M | ﹤0.01% |
73,905
-17,110
| -19% | -$492K |
2015 Q3
43 quarters
|
|
2971
Velocity Financial
VEL
$604M
| $2.29M | ﹤0.01% |
124,130
+36,396
| +41% | +$662K |
2025 Q4
2 quarters
|
|
2972
Central Garden & Pet Co Class A
CENTA
$2.45B
| $2.28M | ﹤0.01% |
58,897
-22,275
| -27% | -$777K |
2013 Q2
52 quarters
|
|
2973
ARKO Corp
ARKO
$427M
| $2.28M | ﹤0.01% |
283,585
+194,627
| +219% | +$1.36M |
2024 Q4
6 quarters
|
|
2974
CALL
Sweetgreen
SG
$1.17B
| $2.28M | ﹤0.01% |
258,300
-16,800
| -6% | -$128K |
2025 Q4
2 quarters
|
|
2975
Parsons
PSN
$5.24B
| $2.28M | ﹤0.01% |
43,431
-13,212
| -23% | -$714K |
2019 Q2
28 quarters
|
|
Similar funds
D.E. Shaw & Co's Q2 2026 Portfolio in Review
As of Q2 2026, D.E. Shaw & Co held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
D.E. Shaw & Co deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- D.E. Shaw & Co's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
- D.E. Shaw & Co's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- D.E. Shaw & Co fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- D.E. Shaw & Co's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- D.E. Shaw & Co opened 872 new positions and closed 527 in Q2 2026.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.